The Road to Hepatitis C Virus Cure: Practical Considerations from a Health System's Perspective

M Cabell Jonas; Bernadette Loftus; Michael A Horberg

doi:10.1016/j.idc.2018.02.007

The Road to Hepatitis C Virus Cure: Practical Considerations from a Health System's Perspective

Infect Dis Clin North Am. 2018 Jun;32(2):481-493. doi: 10.1016/j.idc.2018.02.007.

Authors

M Cabell Jonas¹, Bernadette Loftus², Michael A Horberg³

Affiliations

¹ Mid-Atlantic Permanente Medical Group, PC, 2101 East Jefferson Street, Rockville, MD 20852, USA. Electronic address: Cabell.Jonas@kp.org.
² Mid-Atlantic Permanente Medical Group, PC, 2101 East Jefferson Street, Rockville, MD 20852, USA.
³ Mid-Atlantic Permanente Medical Group, PC, Mid-Atlantic Permanente Research Institute, 2101 East Jefferson Street, Rockville, MD 20852, USA.

PMID: 29778267
DOI: 10.1016/j.idc.2018.02.007

Abstract

Hepatitis C virus infection remains a significant global health problem. Many individuals are unaware of their infection or disease stage. Innovations in care that promote rapid and easy identification of at-risk populations for screening, comprehensive diagnostic screening, and triage to curative direct-acting antiviral medications will accelerate efforts to eradicate hepatitis C.

Keywords: Cascade of care; Clinical pathway; Hepatitis C virus; Infectious disease screening; Viral hepatitis.

Publication types

Review

MeSH terms

Antiviral Agents / therapeutic use
Disease Eradication / methods*
Disease Eradication / statistics & numerical data
Hepacivirus / drug effects
Hepatitis C / diagnosis
Hepatitis C / drug therapy*
Hepatitis C / epidemiology
Hepatitis C / prevention & control
Hepatitis C, Chronic / diagnosis
Hepatitis C, Chronic / drug therapy*
Hepatitis C, Chronic / epidemiology
Hepatitis C, Chronic / prevention & control*
Humans
Mass Screening
United States / epidemiology

Substances

Antiviral Agents